Prevalence of general and abdominal obesity and its relationship with opium, total opiate drugs, and chronic smoking: Fasa cohort study

Obesity and drug use are two major global issues today. This study aimed to evaluate the relationship between alcohol and tobacco use with general and central obesity. The data of the longitudinal population-based study were collected from the basis of the Fasa Cohort Study (FACS). Participants were 10141 people with 35–70 years old. Data were analyzed by SPSS 20 software. Binary logistic regression (BLR) was used for modelling. A significance level (α) less than 0.05% was considered for hypothesis testing. Of the total participants (N = 10104), 54.8% (n = 5539) were women. The prevalence of central obesity in terms of waist circumference (WC), waist to hip ratio (WHR), and waist to height ratio (WHtR) were calculated 48.20% (N = 4871), 79.50% (N = 8032), and 83.30% (N = 8314). The Odds Ratio (OR) adjusted of Abnormal body mass index (BMI) for Opium and chronic smoking were 0.54 (CI: 0.47–0.63) and 0.47 (CI:0.40–0.56). OR adjusted Abnormal WC for opium and chronic smoking were calculated 0.65 (CI: 0.53–0.80) and 0.57 (CI:0.46–0.72), respectively. Three variables of opium (OR = 0.54, CI: 0.46–0.64), total opiate drugs (OR = 1.46, CI:1.16–1.83) and chronic smoking (OR = 0.58, CI: 0.48–0.70) remained in the modeling for Abnormal WHR. Which were statistically significant. Significant and inverse relationships were found between obesity and opium, total opiate drugs, and chronic smoking. •The prevalence of central obesity was high in the Fasa Cohort Study.•Significant and inverse relationships were found between obesity and opium, total opiate drugs, and chronic smoking.•People who use drugs are less obese. But it can not be concluded that drugs and chronic smoking can be prescribed for weight loss.